SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-295412
Filing Date
2011-11-03
Accepted
2011-11-03 17:20:37
Documents
10
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d249127d10q.htm 10-Q 540553
2 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 d249127dex311.htm EX-31.1 10299
3 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 d249127dex312.htm EX-31.2 10291
4 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 - SECTION 906 d249127dex321.htm EX-32.1 3625
5 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 - SECTION 906 d249127dex322.htm EX-32.2 3617
  Complete submission text file 0001193125-11-295412.txt   1849518

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bcrx-20110930.xml EX-101.INS 225065
7 XBRL TAXONOMY EXTENSION SCHEMA bcrx-20110930.xsd EX-101.SCH 8693
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcrx-20110930_cal.xml EX-101.CAL 32252
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcrx-20110930_lab.xml EX-101.LAB 99433
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcrx-20110930_pre.xml EX-101.PRE 59781
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 111178608
SIC: 2836 Biological Products, (No Diagnostic Substances)